Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesPayablesPreferred Stock LiabilitiesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aimei Health Technology (AFJK) Non-Current Deffered Revenue (2023 - 2025)

Aimei Health Technology (AFJK) has 3 years of Non-Current Deffered Revenue data on record, last reported at $690000.0 in Q3 2025.

  • On a quarterly basis, Non-Current Deffered Revenue changed 0.0% to $690000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $690000.0, a 0.0% change, with the full-year FY2024 number at $690000.0, changed 0.0% from a year prior.
  • Non-Current Deffered Revenue reached $690000.0 in Q3 2025 per AFJK's latest filing, roughly flat from $690000.0 in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for AFJK hit a ceiling of $690000.0 in Q4 2023 and a floor of $690000.0 in Q4 2023.
  • A 3-year average of $690000.0 and a median of $690000.0 in 2023 define the central range for Non-Current Deffered Revenue.
  • On a YoY basis, Non-Current Deffered Revenue climbed as much as 0.0% in 2024 and fell as far as 0.0% in 2024.
  • Tracing AFJK's Non-Current Deffered Revenue over 3 years: stood at $690000.0 in 2023, then changed by 0.0% to $690000.0 in 2024, then changed by 0.0% to $690000.0 in 2025.
  • Business Quant data shows Non-Current Deffered Revenue for AFJK at $690000.0 in Q3 2025, $690000.0 in Q2 2025, and $690000.0 in Q1 2025.